ConductScience.org, home

Paper40765417

Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects.

Li P and 6 others. Nanomedicine (Lond), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects. Papers, record 40765417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40765417

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects.
PubMed
Journal
Nanomedicine (Lond)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li PPing
2Wang SShibing
3Shou HHuafeng
4Shan YYiyi
5Wang JJianwei
6Mou XXiaozhou
7Zhang YYouni

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SeleniumMajor topic
Cardiovascular DiseasesMajor topic
NanoparticlesMajor topic
NanomedicineMajor topic
Humans
Animals
Antioxidants

Source PubMed

Download CSV of topics

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131469318Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.Artif Cells Nanomed Biotechnol2019https://conductscience.org/library/papers/31469318PubMed
230703423Construction of arabinogalactans/selenium nanoparticles composites for enhancement of the antitumor activity.Int J Biol Macromol2019https://conductscience.org/library/papers/30703423PubMed
314583345Free radical scavenging efficiency of Nano-Se in vitro.Free Radic Biol Med2003https://conductscience.org/library/papers/14583345PubMed
440379216Artificial lipids and macrophage membranes coassembled biomimetic nanovesicles for thoracic aortic dissection treatment.J Control Release2025https://conductscience.org/library/papers/40379216PubMed
531573569Systematic acute and subchronic toxicity evaluation of polysaccharide-protein complex-functionalized selenium nanoparticles with anticancer potency.Biomater Sci2019https://conductscience.org/library/papers/31573569PubMed
628499854Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.Eur J Pharm Biopharm2017https://conductscience.org/library/papers/28499854PubMed
733905703Selenium nanoparticles inhibit the formation of atherosclerosis in apolipoprotein E deficient mice by alleviating hyperlipidemia and oxidative stress.Eur J Pharmacol2021https://conductscience.org/library/papers/33905703PubMed
828056992Antioxidant capacities of the selenium nanoparticles stabilized by chitosan.J Nanobiotechnology2017https://conductscience.org/library/papers/28056992PubMed
931051453Biosynthesis of Selenium Nanoparticles using yeast Nematospora coryli and examination of their anti-candida and anti-oxidant activities.IET Nanobiotechnol2019https://conductscience.org/library/papers/31051453PubMed
1025248917A simple sonochemical approach for synthesis of selenium nanostructures and investigation of its light harvesting application.Ultrason Sonochem2015https://conductscience.org/library/papers/25248917PubMed
1135997450Unveiling Antimicrobial and Insecticidal Activities of Biosynthesized Selenium Nanoparticles Using Prickly Pear Peel Waste.J Funct Biomater2022https://conductscience.org/library/papers/35997450PubMed
1235624786The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder.Antioxidants (Basel)2022https://conductscience.org/library/papers/35624786PubMed
1334121366Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics.Adv Healthc Mater2021https://conductscience.org/library/papers/34121366PubMed
1439094922Unveiling Green Synthesis and Biomedical Theranostic paradigms of Selenium Nanoparticles (SeNPs) - A state-of-the-art comprehensive update.Int J Pharm2024https://conductscience.org/library/papers/39094922PubMed
1535646508Citric acid-mediated green synthesis of selenium nanoparticles: antioxidant, antimicrobial, and anticoagulant potential applications.Biomass Convers Biorefin2022https://conductscience.org/library/papers/35646508PubMed
1620306235Regulation of redox signaling by selenoproteins.Biol Trace Elem Res2010https://conductscience.org/library/papers/20306235PubMed
1733849566Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation.J Nanobiotechnology2021https://conductscience.org/library/papers/33849566PubMed
1836741999Preparation of nano-selenium from chestnut polysaccharide and characterization of its antioxidant activity.Front Nutr2022https://conductscience.org/library/papers/36741999PubMed
1932077990Nanobiotechnology approach in intracellular selenium nanoparticle synthesis using Saccharomyces cerevisiae-fabrication and characterization.Arch Microbiol2020https://conductscience.org/library/papers/32077990PubMed
2033323558Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase.Aging (Albany NY)2020https://conductscience.org/library/papers/33323558PubMed

See all 110 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42528870Seasonal regulation of selenium biofortification in tea through Se-rich organic fertilizer application.Front Plant Sci2026https://conductscience.org/library/papers/42528870PubMed
42123474Amelioration of 5-Fluorouracil-Induced Hepatorenal Toxicity by Epigallocatechin Gallate-Functionalized Selenium Nanoparticles: A Multi-Targeted Protective Approach.Int J Mol Sci2026https://conductscience.org/library/papers/42123474PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40765417

GET https://conductscience.org/api/papers/v1/40765417/references?page=2